The Chemours Co (CC)

8.84
NYSE : Basic Materials
Prev Close 9.16
Day Low/High 8.55 / 9.13
52 Wk Low/High 3.06 / 12.30
Avg Volume 4.60M
Exchange NYSE
Shares Outstanding 181.47M
Market Cap 1.66B
P/E Ratio N/A
Div & Yield 0.12 (1.30%)
Quant Rating on 4:01 PM EDT 7/22/2016

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DRH, LBTYB, REXR, STFC Downgrades: NWLI, VLP Initiations: CC, FOGO Read on to get TheStreet Quant Ratings' detailed report:

FB, GOOGL, C: Jim Cramer's Views

Cramer shares his views on how the market rallying is good news for some stocks. Facebook, Google and Citigroup are among the stocks discussed.

Closing Bell: Chemours Spikes on Jury Verdict; U.S. Stocks Rally

Wall Street closed out the holiday-shortened week with a bang.

S&P 500 Soars to Near Record Close as Jobs Report Brings Relief Over U.S. Economy

Wall Street closed out the holiday-shortened week with a bang. Stocks bagged major gains after a blowout jobs report brought relief over the state of the U.S. economy.

S&P 500 Hovers at Records as Jobs Report Brings Economic Confidence

Stocks jump Friday after a blockbuster jobs report assures investors recent weakness was an aberration.

Chemours (CC) Stock Surges on Light Punitive Damages in DuPont Case

Chemours (CC) stock is rising today after a jury assigned just $500,000 in punitive damages to DuPont in a chemical dumping case.

Cramer: Amazon Hits All-Time High Without Retail Folding

And that's distinctly good news for the overall market.

Chemours Signs Definitive Agreement To Sell Sulfur Products To Veolia

Agreement Marks Completion of Chemical Solutions Portfolio Review--Part of Chemours Transformation Plan

'Mad Money' Lightning Round: Take Lowe's Over Lumber Liquidators

Crmer prefers Nvidia over Western Digital and LAM Research over Micron Technology.

Jim Cramer's 'Mad Money' Recap: The Bull Is Napping

The rally has been strong and the bull market is taking a deserved rest, Cramer says.

Here’s Short-Seller Andrew Left’s Latest Target

Shares of Chemours plunged on Friday on the heels of a bearish report written by short-seller Andrew Left of Citron Research.

Trending Tickers: SBUX , CC, BAC, ETFC, DNKN

U.S. markets falter Friday after an especially weak jobs report. 

Chemours (CC) Stock Continues Slide, Issues Response to Citron Report

Chemours (CC) stock is down from yesterday after a Citron report said the company was 'purposely designed for bankruptcy,' Chemours issued a response to that claim.

Short-Seller Cites 'Evil' of DuPont Spinoff Chemours

Andrew Left says he feels 'guilty' bringing up the stock issue when the humanitarian issue is much bigger.

Notable Thursday Option Activity: CC, SCOR, IMMU

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Chemours Co , where a total volume of 24,636 contracts has been traded thus far today, a contract volume which is representative of approximately 2.5 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 76% of CC's average daily trading volume over the past month, of 3.2 million shares.

Why Chemours (CC) Stock Is Falling Today

Chemours (CC) stock is down in late-afternoon trading after Citron Research's Andrew Left took aim at the company.

David Einhorn Loves These 3 Stocks -- but You Should Sell Them

Here's a technical look at three of Einhorn's favorite stocks for 2016 that deserve the boot from your portfolio.

10 Stocks Billionaire David Einhorn Loves in 2016

David Einhorn is a man of many talents, including playing poker -- and watching where he stacks his chips investment-wise is a worthwhile endeavor, too.

Chemours Begins Commercial Operations Of New Altamira TiO2 Line In Mexico

Bryan Snell, Business President, Will Discuss Chemours Business and How Expansion Supports Chemours Transformation Plan at Goldman Sachs Basic Materials Conference Today

Chemours To Invest In Expanded Capacity For High Growth Opteon™ Products

This Investment in a Cornerstone Growth Opportunity is Part of Company's Transformation Plan

Chemours Signs Definitive Agreement To Sell Clean And Disinfect Business To LANXESS

Agreement Moves Chemours Closer to Completing Strategic Review of Chemical Solutions

After a 90% Gain Over the Last Three Months, Is Little-Known Chemours Still a Buy?

Goldman Sachs just upgraded this often ignored chemical maker. We determine whether Chemours is about to lose steam or continue its winning ways.

Jim Cramer's Top Takeaways: CST Brands, Chemours, Adobe, Salesforce, Workday

Cramer says if you'd done your homework you could've bought Adobe, Salesforce and Workday cheap when LinkedIn and Tableau Software brought them lower.